ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

スルファピリジン

Sulfapyridine

HCID 5336
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
144-83-2
標準SMILES
Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1
InChIKey
GECHUMIMRBOMGK-UHFFFAOYSA-N
分子式
C11H11N3O2S
平均分子量
249.29 g/mol
単同位体質量
249.05719778

概要

Sulfapyridine appears as odorless or almost odorless white or yellowish-white crystalline powder. Very slightly bitter taste. Aqueous solution is neutral. (NTP, 1992)

名称と識別子

優先名称
Sulfapyridine
IUPAC
4-amino-N-pyridin-2-ylbenzenesulfonamide
現地名
スルファピリジン
英語名
Sulfapyridine
分子式
C11H11N3O2S
分子量
249.29

名称と別名

sulfapyridine144-83-2Sulphapyridine2-Sulfapyridine2-SulfanilamidopyridinePiridazolSulfidineDagenanSulfidinStreptosilpyridineCoccoclasePlurazol
名称をさらに表示
スルファピリジン2-スルファニルアミドピリジン4-アミノ-N-(2-ピリジニル)ベンゼンスルホンアミドピリアミドN-(ピリジン-2-イル)-4-アミノベンゼンスルホンアミドユーバシンピリダゾール4-アミノ-N-(2-ピリジル)ベンゼンスルホンアミドオイバシンコッコクラーセダゲナンスルファピリジン標準品2-(4-アミノベンゼンスルホンアミド)ピリジンN'-2-ピリジルスルファニリド4-アミノ-N-ピリジン-2-イルベンゼンスルホンアミド2-(Sスルファニルアミド)ピリジン4-アミノ-N-(ピリジン-2-イル)ベンゼン-1-スルホンアミドN-(4-アミノフェニルスルホニル)-1,2-ジヒドロピリジン-2-イミンN-(2-ピリジル)-4-アミノベンゼンスルホンアミドN-(2-ピリジニル)-4-アミノベンゼンスルホンアミドSulfapyridinTHAP114-AMINO-N-[2-PYRIDYL]BENZENE SULFONAMIDE2-hydroxybenzenecarboxylic acid (salicylic acid)RoninA-499m+b693TrianonAdiplon
PyriamidPyridazolEubasin2-SulfanilylaminopyridineEubasinumRelbapiridinaSeptipulmonThioseptal

物性

構造計算による物性補完中

XLogP
0
極性表面積
93.5 Ų
水素結合供与体数
2
水素結合受容体数
5
回転可能結合数
3
重原子数
17
形式電荷
0
複雑度
331

実験および物理化学的性質

Drugs · 5 件

Pharmaceuticals -> Metabolite of Sulfasalazine

Pharmaceuticals -> Antibiotics (Sulfonamide)

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals

SpringerMaterials PropertiesFusion temperature
LogP · 2 件

0.9

0.35

Solubility · 3 件

less than 1 mg/mL at 72 °F (NTP, 1992)

2.35e-01 g/L

33.1 [ug/mL] (The mean of the results at pH 7.4)

Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Melting Point · 2 件

376 to 379 °F (NTP, 1992)

192 °C

Physical Description · 2 件

Sulfapyridine appears as odorless or almost odorless white or yellowish-white crystalline powder. Very slightly bitter taste. Aqueous solution is neutral. (NTP, 1992)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 5 件

This chemical does not meet GHS hazard criteria for 12% (6 of 50) of reports.

Danger

H300 (72%): Fatal if swallowed [Danger Acute toxicity, oral]

P203, P260, P261, P264, P270, P272, P273, P280, P301+P316, P302+P352, P308+P316, P318, P321, P330, P333+P317, P362+P364, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 50 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory Information · 2 件

REACH registered substance: Sulfapyridine (EC: 205-642-7)

Sulfapyridine: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Other Safety InformationIMAP assessments - Benzenesulfonamide, 4-amino-N-2-pyridinyl-: Human health tier I assessment
Fire HazardsFlash point data for this chemical are not available; however, it is probably combustible. (NTP, 1992)
Health Hazards · 1 件

SYMPTOMS: Symptoms of exposure to this compound include fever, rash, agranulocytosis, deposition of crystals in the urinary tract with consequent hematuria or anuria, nausea, vomiting, cyanosis, sensitization and, rarely, granulocytopenia. Other symptoms include acute transient myopia, conjunctivitis, keratitis, disturbances of the optic nerve and retina, temporary impairment of depth perception, swelling of the eyelids, photophobia, lacrimation, Stevens-Johnson syndrome, Lyell syndrome, amblyopia, central scotoma and optic neuritis, usually with papilledema. It can induce crystalluria.

Reactive GroupAmines, Phosphines, and Pyridines

化学と産業

薬理情報

ATC Code · 2 件

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

Protein BindingApproximately 50% bound to plasma proteins.
Pharmacodynamics · 1 件

Sulfapyridine is a sulfonamide antibiotic. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of <i>p</i>-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections. Their antibacterial action is inhibited by pus.

Mechanism of Action · 1 件

Sulfapyridine is a competitive inhibitor of the bacterial enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid by means of processing the substrate para-aminobenzoic acid (PABA). Dihydropteroate synthetase activity is vital in the synthesis of folate, and folate is required for cells to make nucleic acids, such as DNA or RNA. So if DNA molecules cannot be built, the cell cannot divide.

Biological Half-Life6-14 hours.
Metabolism/Metabolites · 2 件

Hepatic.

Sulfapyridine has known human metabolites that include Sulfapyridine, N-acetyl.

MeSH Pharmacological Classification · 2 件

関連反応

9 件
反応記録を作成
HRID 122078 の反応式
HRID 122078反応物として
HRID 214740 の反応式
HRID 214740反応物として
HRID 840816 の反応式
HRID 840816反応物として
HRID 1248965 の反応式
HRID 1248965反応物として
HRID 1263962 の反応式
HRID 1263962反応物として
HRID 1391491 の反応式
HRID 1391491反応物として
HRID 1639484 の反応式
HRID 1639484生成物として
HRID 1790179 の反応式
HRID 1790179反応物として
前へ1 / 2 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
144-83-2
PubChem CID
5336
DTXSID
DTXSID3026067
ChEMBL
CHEMBL700
ChEBI
CHEBI:132842
UNII
Y5V2N1KE8U
EC Number
205-642-7
Nikkaji
J5.831I

Solid

Dissociation Constants8.43
Collision Cross Section · 6 件

150.94 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

142.3 Ų [M+H]+ [CCS Type: TW]

150.8 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

163.9 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with Waters Major Mix]

151.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

156.54 Ų [M-H]-

物理化学的性質

融点
191 · 191-193°C
沸点
473.5 · 473.5±51.0 °C(Predicted)
比重(密度)
1.322 · 1.3220 (rough estimate)
屈折率
1.674 · 1.6740 (estimate)
貯蔵温度
Keep in dark place,Sealed in dry,Room Temperature
溶解性
DMSO(微量)、メタノール(微量)
外見
Solid
酸解離定数(Pka)
8.48 · pKa 8.48(H2O t = 25 I = 0.05) (Uncertain)
色
ホワイトからオフホワイト
水溶解度
0.1 g/100 · <0.1 g/100 mL で 22 ºC
Merck
14 · 14,8938
BRN
222065 · 222065
安定性
安定。可燃性。光から保護します。強力な酸化剤とは相容れない。
主な用途
法医学と毒物学医薬品(低分子化合物)
InChI
1S/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14)
InChIKey
GECHUMIMRBOMGK-UHFFFAOYSA-N
SMILES
Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2
CAS データベース
144 · 144-83-2(CAS DataBase Reference)
NISTの化学物質情報
Sulfapyridine(144-83-2)
EPAの化学物質情報
Sulfapyridine (144-83-2)

化学的性質

化学的特性White to Off-White Solid

Reactivity ProfileSULFAPYRIDINE is an amino acid. Slowly darkens on exposure to light (NTP, 1992). Soluble in both acidic and basic aqueous solutions
Air and Water ReactionsInsoluble in water.
Hazard Classes and CategoriesAcute Tox. 2 (72%)

安全と保護具

Fire FightingFires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)
First Aid · 1 件

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. If symptoms (such as redness or irritation) develop, immediately transport the victim to a hospital.

Nonfire Spill Response · 1 件

SMALL SPILLS AND LEAKAGE: If a spill of this chemical occurs, FIRST REMOVE ALL SOURCES OF IGNITION, then you should dampen the solid spill material with acetone and transfer the dampened material to a suitable container. Use absorbent paper dampened with acetone to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Solvent wash all contaminated surfaces with acetone followed by washing with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Personal Protective Equipment (PPE) · 1 件

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)

安全データ

wgk
2
tsca
TSCA listed
rtecs
DA9625000
毒性
LD50 orally in mice: 7.5 mg/g (Wien)
hs_code
29350010
risk_code
36/37/38
hazard_code
Xi
safety_code
22-24/25-36-26
hazard_class
IRRITANT
Hazard Classifications
Repr. 2
ストレージクラス
11 - Combustible Solids

Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.

Drugs used to treat or prevent skin disorders or for the routine care of skin.

Absorption, Distribution and ExcretionApproximately 60-80%
Cellular LocationsMembrane

用途と製造

UsesUse (kg) in Switzerland (2009): >1000
Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan
General Manufacturing InformationBenzenesulfonamide, 4-amino-N-2-pyridinyl-: ACTIVE
応用分野 · 3 件

説明Sulfapyridine is a sulfonamide antibiotic with antibacterial and anti-inflammatory activities. It is also a metabolite of sulfasalazine formed through bacterial conversion in the colon. It is active against strains of Y. enterocolitica and Salmonella (MICs = 3.1-25 and 25-100 μg/ml, respectively), as well as S. aureus (MBC = 0.8 μM). It is an inhibitor of recombinant P. carinii dihydropteroate synthetase (DHPS; IC50 = 0.18 μM). Sulfapyridine scavenges peroxyl radicals in an oxygen radical absorbance capacity (ORAC) assay. It inhibits histamine release induced by compound 48/80 from isolated rat peritoneal mast cells in a dose-dependent manner. Sulfapyridine (1 μg/kg) also inhibits compound 48/80-induced systemic allergic reaction in rats. Formulations containing sulfapyridine have previously been used in the treatment of dermatological conditions and ulcerative colitis.

使用Used in treatment of dermatitis herpetiformis; antibacterial.

一般的な説明Sulfapyridine’s plasma half-life is 9 hours.This compound is a white, crystalline, odorless, and tastelesssubstance. It is stable in air but slowly darkens on exposureto light. It is soluble in water (1:3,500), in alcohol(1:440), and in acetone (1:65) at 25°C. It is freely soluble indilute mineral acids and aqueous solutions of sodium andpotassium hydroxide. The pKa is 8.4. Its outstanding effectin curing pneumonia was first recognized by Whitby; however,because of its relatively high toxicity, it has been supplantedlargely by sulfadiazine and sulfamerazine. Severalcases of kidney damage have resulted from acetylsulfapyridinecrystals deposited in the kidneys. It also causes severenausea in most patients. Because of its toxicity, it is usedonly for dermatitis herpetiformis.Sulfapyridine was the first drug to have an outstandingcurative action on pneumonia. It gave impetus to the studyof the whole class of N1 heterocyclically substituted derivativesof sulfanilamide.

調製方法

純化方法Crystallise sulfapyridine from 90% acetone and dry it at 90o. Its solubility in Me2CO, EtOH and H2O is 1.5%, 0.22% and 0.02%, respectively. [Winterbottom J Am Chem Soc 62 160 1940, Beilstein 22 III/IV 3978.]

上流・下流製品情報

上流原料

2-アミノピリジン4-Nitro-N-2-pyridinyl-benzenesulphonamideDiazene, 1,2-diphenyl-, stereoisomer4-Chloro-N-(pyridin-2-yl)benzenesulfonamideアセチルスルファピリジン4-アミノベンゼンスルホニルフルオリド4-アセトアミドベンゼンスルホニルクロリドアセトアニリドスルファニルアミド

下流製品

スルファサラジン

補足説明

定義ChEBI: A sulfonamide consisting of pyridine with a 4-aminobenzenesulfonamido group at the 2-position.